Safety Risk Communication for Medical Products

Learn how to enhance the effectiveness of safety risk communication in light of evolving regulatory expectations by attending this course.

Back to Agenda

Session 9: Who’s Responsible for Communicating Drug Safety Information?

Session Chair(s)

Meredith Smith, PhD, MPA, FISPE

Senior Director, Implementation Science Pillar Lead

Evidera, Inc, United States

This session will examine the role of regulatory authorities, pharmaceutical companies, and healthcare professionals in drug safety communication and will include an introduction to drug product labeling and drug advertising regulations in the US.